bioAffinity Share Price

bioAffinity Share Price

NASDAQ: BIAF | Micro Cap | Healthcare
$1.73
-$0.21 (-10.82%) Last updated on 20 Nov, 2026 | 23:11 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

bioAffinity Stock Performance

Open
N/A
Prev. Close
$1.94
Circuit Range
N/A
Day Range
N/A
Year Range
$0.39 - $20.22
Volume
N/A
Average Traded
N/A

bioAffinity Share Price Chart

Line chart of the bioAffinity price trend over the selected period. The price fell overall, ranging from 1.73 to 1.73, ending at 1.73.
$0.00$0.00
L
Show Current Price
H

bioAffinity Stock Fundamentals & Key Indicators

Market Cap
$2.98M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-8.47
Revenue (TTM)
$6.16B
Return On Equity (TTM)
-393.69%
Profit Margin
-242.05%
Debt to Equity
0.19
Quarterly Earnings Growth YoY
-68.15%

bioAffinity Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.59$1.35$1.51$1.07
Net Profit-$3.14-$3.63-$3.37-$5.28
Net Profit Margin-197.48%-268.89%-223.18%-493.46%
Income ChangeN/A-15.61%7.16%-56.68%

bioAffinity Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$2.53$9.36$6.16
Net Profit-$8.15-$7.94-$9.04-$14.91
Net Profit MarginN/A-313.83%-96.58%-242.05%
Income ChangeN/A2.58%-13.85%-64.93%

bioAffinity Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets3.43.824.250.22
Current Assets7.572.73.9711.96
Total Assets10.966.518.2212.18
Non Current Liabilities0.780.811.120.0
Current Liabilities2.913.12.251.14
Total Liabilities3.683.913.371.14
Shareholders' Equity7.282.64.8611.04

bioAffinity Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-9.33-7.26-6.04-4.07
Investing-0.06-0.08-2.21-0.22
Financing14.735.63-0.3414.34

About bioAffinity

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

bioAffinity Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.98
$1.73
-42.14%
Oct 2026
$6.66
$2.99
-55.87%
Sep 2026
$7.51
$6.78
+32.32%
Aug 2026
$0.59
$5.12
+716.59%
Jul 2026
$0.85
$0.63
-23.35%
Jun 2026
$1.74
$0.82
-51.02%
May 2026
$2.41
$1.67
-33.20%
Apr 2026
$4.32
$2.50
-35.23%
Mar 2026
$1.01
$3.86
+274.76%
Feb 2026
$1.18
$1.03
-10.43%
Jan 2026
$1.25
$1.15
-7.26%
Dec 2025
$1.54
$1.24
-15.93%

bioAffinity Share Price FAQs